IGF2BP3 promotes aggressive phenotypes in colorectal cancer, lung tumorigenesis by affecting p53 stability, and recent reports suggest its involvement in bladder cancer cell proliferation [21–25]. The gene discussed is IGF2BP3; the disease is urinary bladder cancer.